Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir

Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir

Currently, interferon alpha and nucleos(t)ide analogues (NAs) are clinically available to treat hepatitis B virus (HBV) infection. Several NAs, including lamivudine (LMV), adefovir (ADV), entecavir (ETV) and tenofovir (TDF or TAF) have been approved and administered to chronic hepatitis B (CHB) pati...

Full description

Bibliographic Details
Main Authors: Juhee Won, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Jong Chul Kim, Soree Park, Nayeon Kim, Byengjune Jae, Kyun-Hwan Kim
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
hepatitis B virus
besifovir
reverse transcription
nucleos(t)ide analogue
drug resistance
Online Access:https://www.mdpi.com/2227-9059/10/7/1637

Internet

https://www.mdpi.com/2227-9059/10/7/1637

Similar Items